Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Seeking Alpha
3d
Exelixis gains after win in patent fight with MSN over Cabometyx
Exelixis (NASDAQ:EXEL) jumped 6% after winning in a patent fight with generic drug make MSN Laboratories over Cabometyx. The asserted claim of the '349 patent not infringed and not invalid ...
1mon
on MSN
Exelixis unveils additional data on Cabometyx for neuroendocrine tumors
Exelixis is pursuing an additional approval for Cabometyx in neuroendocrine tumors. The U.S. FDA has assigned an action date ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Judge unseals new evidence
Preliminary cause of death
School shooting report
PG&E shuts off power
La Nina could arrive soon
Three Americans detained
Fire prompts evacuations
Republicans appeal ruling
NYC giant pigeon sculpture
Calif. oil refinery closure
OK classroom Bible suit
To furlough 700 workers
NK sending troops to RU?
Lebanese citizens get TPS
Eases voting rules
‘Full Self-Driving’ probe
Nevada US Senate debate
988 Lifeline georouting
FAA opens new safety review
Sells for $9M at auction
At decade-high level
Teen tobacco use falls
Dow closes at record high
Emergency abortion ruling
Afghan man denied release
$4M LAPD fentanyl seizure
US charges ex-Indian spy
School shooting indictment
Sued for alleged misconduct
Space export curbs eased
Feedback